Skip to main content
. 2018 Sep 7;9:421. doi: 10.3389/fpsyt.2018.00421

Table 5.

All participants' ERP N4 mean latencies [mean (SD), ms] and mean amplitudes [mean (SD), μV] *.

Scalp regions IAG NCG
Compatible trials Incompatible trials Compatible trials Incompatible trials
Latencies Amplitudes Latencies Amplitudes Latencies Amplitudes Latencies Amplitudes
Frontal lobe 405 (14) −4.0 (0.6) 403 (15) −3.9 (0.7) 403 (15) −4.1 (0.8) 400 (19) −4.3 (1.0)
Parietal lobe 400 (19) −4.1 (0.8) 402 (19) −4.2 (0.9) 401 (11) −4.1 (0.7) 405 (17) −4.5 (0.8)
Central lobe 401 (17) −4.0 (0.5) 402 (17) −4.2 (0.6) 400 (19) −4.3 (0.6) 406 (14) −4.6 (0.7)
Temporal lobe (T3) 406 (15) −4.3 (0.6) 401 (13) −4.1 (0.5) 404 (16) −4.2 (0.8) 402 (18) −4.1 (0.9)
Temporal lobe (T4) 399 (17) −4.1 (1.0) 407 (18) −4.2 (0.5) 401 (17) −4.0 (0.6) 400 (16) −4.0 (0.6)
Occipital lobe 402 (18) −4.3 (0.8) 402 (17) −4.0 (0.6) 405 (18) −4.1 (0.8) 406 (16) −4.2 (0.6)
*

The sum of all corresponding scalp region latencies and amplitudes divided by the number of electrode sites are the mean latencies and mean amplitudes, respectively.